Get ready for a thrilling baseball story that's about to unfold! The New York Yankees have just signed a minor league contract with infielder Paul DeJong, a move that's sure to spark some debate among fans and analysts alike.
Jorge Castillo, a renowned baseball reporter, brings us the scoop. DeJong, at 32 years old, has the potential to earn $1 million if he secures a spot on the team. With nine years of experience under his belt, DeJong made a name for himself as the St. Louis Cardinals' everyday shortstop in 2017, even finishing second in the National League Rookie of the Year voting. Two years later, he was an All-Star, showcasing his power with 30 home runs and an impressive 5.2 bWAR. However, replicating that success has proven challenging.
Last season, DeJong's performance with the Washington Nationals was modest, batting .228 with six home runs and a .642 OPS in 57 games. He showcased his versatility by starting games at third, second, and even first base. But here's where it gets interesting: the Yankees have already re-signed Amed Rosario, another veteran utility player, to seemingly platoon with Ryan McMahon at third base. So, what does DeJong's addition mean for the team's infield strategy?
And this is the part most people miss: the Yankees are currently dealing with an injury to their shortstop, Anthony Volpe, who underwent shoulder surgery in October. Other infield options include Jose Caballero and Oswaldo Cabrera, who unfortunately suffered a season-ending knee injury last May. With these factors in mind, the Yankees' decision to bring in DeJong raises some intriguing questions.
So, what do you think? Is this a smart move by the Yankees, or are they taking a risk? Share your thoughts in the comments below! The baseball world is buzzing, and we want to hear your take on this controversial signing.
